about
Myfortic for the Treatment of Non-infectious Intermediate UveitisEfficacy and Safety of H.P. Acthar® Gel in Subjects With Severe Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis NIPPUA Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitisSuprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious UveitisStudy of the Effectiveness of Ozurdex for the Control of UveitisSuprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious UveitisSafety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat UveitisQuality of Life in Patients With Intermediate UveitisStudy of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS StudySafety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal InsertSafety,Tolerability and Efficacy of Intravitreal LFG316 in Patients With Active Non-infectious Intermediate-, posterior-or Panuveitis ,Sirolimus as Therapeutic Approach to UveitisSafety and Preliminary Efficacy Study of V404 PDS in UveitisSafety &Efficacy of CF101 to Subjects With UveitisIntravitreal Sirolimus as Therapeutic Approach to UveitisA Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-UveitisRandomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate UveitisA Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior UveitisRetisert and Cataract Surgery in Patients With Severe UveitisA Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-UveitisSuprachoroidal Injection of CLS-TA in Subjects Non-infectious UveitisExtension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301Variations in Retinal Nerve Fiber Layer Thickness During Uncomplicated Anterior and Intermediate UveitisStudy of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis PatientsA Controlled, Multi-center Study of the Utilization and Safety of the MK II Inserter and the Safety of the FAI Insert in Subjects With Non-infectious Uveitis Affecting the Posterior Segment of the EyeSafety and Efficacy Study of a Fluocinolone Acetonide Intravitreal (FAI) Insert in Subjects With Chronic Non-infectious Posterior UveitisPilot Project: The Amplicon and Metatranscriptomic Study of Intra and Extra Intestinal Microbiome in Non-infectious Uveitis Disease
P1050
Q61936971-4FD53D86-76F6-4061-99B1-89CF870AE24EQ62024874-65CF3288-2855-4BF4-B758-D2503EE8F9C3Q63830319-10E28B1B-371E-48C4-9C2D-AD46D39C5713Q64216774-A5775EB5-2EAD-4042-8597-7C43A70841ADQ64336946-40E82549-0704-4FCC-9C30-7FE76AEDF1A1Q64601738-998248A2-EDE5-4901-8D90-B09670C0DE5FQ64635446-DE035BD4-7A3D-4F6F-890F-80F244BA3AB9Q64635761-65ABE8C2-4257-4DC8-AC6A-87D2C1845575Q64639117-B676A6C8-C8A9-4996-B95D-DCFF6F915F0BQ64640581-7EAB49AF-8C6B-404A-BF46-59D739FC49E0Q64647147-35225BB8-2098-4069-ABDE-1703454BDE67Q64675548-CE2ED2C1-1327-4A5B-A921-3351752D0914Q65359933-88C7FA4A-84C9-4AAC-AB0B-EBA8FF0EAFE6Q65362140-666D78E8-AF41-4D89-9B79-C13135B16B77Q65375644-65AA2CF8-399C-4B05-8603-F25ED50C5197Q65385401-37348B7E-70F5-4FAF-83CD-08415CE855CFQ65389104-A256E557-CE6B-473B-81A4-07E9DE6085F7Q65390272-127CBF6E-4A85-4C13-BB8F-00FBBB8C299CQ65469682-16E72BDA-C0F6-49CB-A284-E2B21D4486D1Q65473628-F6E425A1-81D0-4E7F-8024-F52EA14AD03BQ66046518-C1DA80ED-6E4D-4C0A-9114-F6A1B0098428Q66078414-B1C252BB-4CF5-4A0A-837D-6439BAC01009Q66082735-1503B57D-BDE1-4366-BCF7-E47567BAAFB9Q66403980-B5C9D46B-B28B-4BF9-A04E-52824A77DEAEQ66405107-4A969441-03AE-4BC3-9585-A23DA3471FAAQ66405315-E9F30331-FA7B-4E49-BF40-D3000ED0AE66Q74277015-CC395939-D6C7-49DF-A3B0-5F3E5271FC40
P1050
description
Human disease
@en
Krankheit
@de
مرض يصيب الإنسان
@ar
name
pars planite
@fr
pars planitis
@en
type
label
pars planite
@fr
pars planitis
@en
altLabel
PARS PLANITIS
@en
Posterior cyclitis
@en
pars plana of ciliary body inflammation
@en
pars plana of ciliary bodyitis
@en
prefLabel
pars planite
@fr
pars planitis
@en
P279
P672
P486
P1692
P1748
P1995
P2888
P2892
P31
P4229
P486
P492
P5270
MONDO:0011644
P672
C11.941.160.478.700
C11.941.879.780.900.300.659
C11.941.879.900.500
P699
DOID:12731